Duck hepatitis B virus (DHBV) shares many basic characteristics with hepatitis B virus (HBV) and is an
attractive model for vaccine development. In this study, DHBV DNA vaccines were designed to express envelope and capsid fusion proteins to enhance the breadth of immune response in ducks. Attenuated Salmonella
typhimurium (SL7207) was used as a carrier and adjuvant to boost the magnitude of immune response. The
results of this study enriched our knowledge of the antigenicity of envelope and capsid fusion proteins in ducks
and demonstrated the value of using attenuated S. typhimurium (SL7207) to deliver DHBV vaccines. In the
future, it is worth further exploring DNA vaccines expressing multiple antigen genes delivered by attenuated S. typhimurium, as well as the therapeutic benefits when applied to the duck model of DHBV infection. See
pages 928–939 by Liu et al. in details. The photo showed here were ducklings inoculated with DHBV DHA
vaccines delivered by attenuated S. typhimurium which was provided by Liu Siyang and Prof. Jia Renyong
from the Avian Disease Research Center, Sichuan Agricultural University, China.